^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MK-0752

    i
    Associations
    News

    Trials

    Company:
    Cancer Research UK, Merck (MSD)
    Drug class:
    γ-secretase inhibitor, Notch inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer (NCT00756717)
    Phase 4
    Loyola University
    Completed
    Last update posted :
    09/04/2019
    Initiation :
    02/14/2008
    Primary completion :
    12/21/2011
    Completion :
    12/21/2011
    ER
    |
    ER positive
    |
    tamoxifen • letrozole • MK-0752